For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Disabled voice excluded from discussion on disability yet again, says advocate
+Print Archive
News - The Simpson Report
Disabled voice excluded from discussion on disability yet again, says advocate
Wednesday 1 July 2020, 06:45 AM

Among the many voices reponding to the detail of the Health and Disability System Review – Final Report Pūrongo Whakamutunga, were advocates from the disability sector and Pacific health. Alan Perrott finds the proposals have not been roundly welcomed
Key points, The Disabled Persons Assembly says it had no meaningful engagement with the Health and Disability System Review Panel.
CCS Disability Action says gi
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.